• Study: Link Between Birth Control Pills and Prostate Cancer?

    by  • 16 November 2011 • General News

    Increased use of birth control pills by women may be linked to the rising prostate cancer in men, according to a study published today in the British Medical Journal Open.

    The study found that countries with the highest number of women on the pill were more likely to have a higher number of men who are diagnosed with prostate cancer. The finding suggests for the first time a potential link between the pill and prostate cancer, the researchers said.  

    It’s unclear what exactly could tie the pill to prostate cancer, but researcher said estrogen hormones released in urine that recycle through the water supply could account for one possible explanation.

    “There’s reason to suggest there’s an environmental component [to prostate cancer] and not solely genetic,” said Dr. Neil Fleshner, head of urology at the University Health Network in Ontario and co-author of the study.

    Previous studies suggest that certain chemicals like pesticides and medication contaminated water are to blame for a rise in endocrine related diseases including certain types of cancer and early onset of puberty.  

    Fleshner agreed their findings produce more questions instead of answers, and their hypothesis is based on speculation.

    Men living in continents like North America and Europe are at higher risk for prostate cancer, and countries within those nations also have a higher use of oral contraceptives, they found.  

    Fleshner and his colleague looked at the use of other types of birth control such as intrauterine device, condoms, and vaginal barriers, but found no association to prostate cancer compared to areas where use of the pill was prevalent.

    “This is just a hypothesis generating idea,” said Fleshner. “Women should not be throwing away the pill because of this.”


    After thirty years in the investment and public relations field, we have switched our focus lobbing between American and European companies facilitating business and licensing opportunities . Starting in the year 2003 L.G.Zangani, LLC has organized the annual event "Pharmafinance" in Milano and Roma. Pharmafinance is unique in its structure and has the ability to expose opportunities generated offering licensing or developing opportunities. Recently we have started the site www.letcombatpain.com creating the first worldwide site for pain news. The site also offers an humanitarian tools where individuals or professionals confronted by unique and rare forms of pain can communicate with all the members of the group simply sending oneemail. This ability of having a mass communication tool can also be used to expose innovative pain products or ideas. Additionally has also been invited as speaker to several conferences in Europe to discuss the uniqueness and functionality of his site .